Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss negatively impacts quality of life, and psychological support can help.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata causes significant financial strain, especially for women and those with severe symptoms.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Deucravacitinib helped a man regrow hair and improve psoriasis.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Early diagnosis of leprosy is crucial to prevent disabilities and spread, even in non-endemic areas.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

People with alopecia areata face challenges but find ways to cope and live fulfilling lives.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Androgenetic alopecia significantly reduces quality of life in men.

Long COVID has severely affected a couple's health, finances, and social life.